Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) saw a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 12,500 shares, a drop of 28.2% from the September 30th total of 17,400 shares. Based on an average daily volume of 29,900 shares, the short-interest ratio is presently 0.4 days.
Arch Therapeutics Trading Up 49.8 %
Shares of Arch Therapeutics stock traded up $0.13 during trading on Monday, reaching $0.39. The company’s stock had a trading volume of 16,600 shares, compared to its average volume of 5,935. The business’s fifty day moving average price is $0.49 and its 200-day moving average price is $0.82. Arch Therapeutics has a one year low of $0.17 and a one year high of $18.00.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last posted its earnings results on Monday, August 19th. The biotechnology company reported ($1.44) earnings per share (EPS) for the quarter. The company had revenue of $0.03 million during the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Featured Articles
- Five stocks we like better than Arch Therapeutics
- How Can Investors Benefit From After-Hours Trading
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Following Congress Stock Trades
- 3 Oil Stocks to Watch Before Earnings Come Out
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
